Summary & Overview

Traumatic Stupor and Coma >1 Hour with MCC: Inpatient Reimbursement Overview

DRG 082 includes traumatic stupor and coma lasting more than one hour with Major Complication or Comorbidity, representing severe traumatic brain injury requiring intensive inpatient care. Proper classification affects Medicare inpatient reimbursement because the Diagnosis-Related Group assignment reflects elevated resource use tied to major complications.

Traumatic Stupor and ComaDRG Traumatic Stupor and Coma >1 Hour with MCCDRG 082Diagnosis-Related GroupInpatient ReimbursementMedicareNeurosurgeryCritical CareTraumaAcute Care

DRG 082 Overview

DRG 082 covers patients admitted with traumatic stupor and coma lasting more than one hour with at least one Major Complication or Comorbidity. This group captures high-acuity traumatic brain injury cases that typically require intensive monitoring, advanced imaging, and prolonged inpatient resources. It matters for Medicare payment because the presence of a Major Complication or Comorbidity increases relative resource use and adjusts reimbursement to reflect higher expected costs. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and the associated payment level.

Clinical Trials

Acute neuroprotective and resuscitation intervention trials: studies testing early hospital-phase interventions aimed at limiting secondary brain injury in patients with prolonged traumatic stupor or coma (duration >1 hour) who present with severe head trauma and major comorbid conditions. These trials typically enroll adults with traumatic brain injury (TBI) requiring intensive monitoring or intracranial pressure management and evaluate short-term physiological endpoints (ICP control, cerebral perfusion, biomarker changes) and safety. Results inform acute care protocols, resource utilization in the ICU, and short-term costs that are directly relevant to both providers managing immediate treatment strategies and payers covering high-intensity inpatient services.
Comparative effectiveness studies of critical-care bundles and surgical timing: pragmatic trials or observational comparative-effectiveness research comparing different combinations of ICU care bundles (for example, protocols for intracranial pressure monitoring, hemodynamic targets, and ventilator strategies) and timing/indications for neurosurgical procedures (decompressive craniectomy, hematoma evacuation) in patients with traumatic stupor/coma and major complications. These studies focus on heterogeneous real-world populations with severe TBI and MCCs to assess in-hospital mortality, complication rates, length of stay, and need for subsequent levels of care. Findings guide best-practice clinical pathways and can influence reimbursement policies by identifying care approaches that improve outcomes while potentially reducing unnecessary resource use.
Post-acute outcomes and functional recovery cohorts: longitudinal studies and registry-based research following survivors of prolonged traumatic stupor/coma with major complications through discharge, rehabilitation, and 6–12+ month outcomes to characterize functional status, cognitive recovery, readmissions, and long-term care needs. These studies enroll patients transitioning from inpatient to post-acute settings and assess predictors of disability, utilization of rehabilitation services, and caregiver burden. Data are critical for providers planning discharge and rehabilitation strategies and for payers evaluating longer-term costs, benefit design for rehabilitation services, and programs aimed at reducing readmissions and durable medical costs.

Acute neuroprotective and resuscitation intervention trials: studies testing early hospital-phase interventions aimed at limiting secondary brain injury in patients with prolonged traumatic stupor or coma (duration >1 hour) who present with severe head trauma and major comorbid conditions. These trials typically enroll adults with traumatic brain injury (TBI) requiring intensive monitoring or intracranial pressure management and evaluate short-term physiological endpoints (ICP control, cerebral perfusion, biomarker changes) and safety. Results inform acute care protocols, resource utilization in the ICU, and short-term costs that are directly relevant to both providers managing immediate treatment strategies and payers covering high-intensity inpatient services.
Comparative effectiveness studies of critical-care bundles and surgical timing: pragmatic trials or observational comparative-effectiveness research comparing different combinations of ICU care bundles (for example, protocols for intracranial pressure monitoring, hemodynamic targets, and ventilator strategies) and timing/indications for neurosurgical procedures (decompressive craniectomy, hematoma evacuation) in patients with traumatic stupor/coma and major complications. These studies focus on heterogeneous real-world populations with severe TBI and MCCs to assess in-hospital mortality, complication rates, length of stay, and need for subsequent levels of care. Findings guide best-practice clinical pathways and can influence reimbursement policies by identifying care approaches that improve outcomes while potentially reducing unnecessary resource use.
Post-acute outcomes and functional recovery cohorts: longitudinal studies and registry-based research following survivors of prolonged traumatic stupor/coma with major complications through discharge, rehabilitation, and 6–12+ month outcomes to characterize functional status, cognitive recovery, readmissions, and long-term care needs. These studies enroll patients transitioning from inpatient to post-acute settings and assess predictors of disability, utilization of rehabilitation services, and caregiver burden. Data are critical for providers planning discharge and rehabilitation strategies and for payers evaluating longer-term costs, benefit design for rehabilitation services, and programs aimed at reducing readmissions and durable medical costs.

OpenPayer

Summary & Overview

Traumatic Stupor and Coma >1 Hour with MCC: Inpatient Reimbursement Overview

DRG 082 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes